Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Israel

Harel 4B Selected Biomed

+ Add to Watchlist

IL30EQY:IT

2,999.02 ILs 24.07 0.81%

As of 00:59:30 ET on 05/21/2015.

Snapshot for Harel 4B Selected Biomed (IL30EQY)

Year To Date: +11.83% 3-Month: -2.54% 3-Year: +0.42% 52-Week Range: 2,540.33 - 3,942.95
1-Month: -5.53% 1-Year: -22.74% 5-Year: -4.85% Beta vs TA-100: 0.90

Mutual Fund Chart for IL30EQY

No chart data available.
  • IL30EQY:IT 2,999.02
  • 1M
  • 1Y
Interactive IL30EQY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IL30EQY

Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.

Inception Date: 01-01-1993 Telephone: -
Managers: -
Web Site: -

Fundamentals for IL30EQY

NAV (on 2015-05-21) 2,999.02
Assets (M) (on 2015-04-30) 20.20
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for IL30EQY

No dividends reported

Fees & Expenses for IL30EQY

Front Load -
Back Load -
Current Mgmt Fee 2.51
Redemption Fee -
12b1 Fee -
Expense Ratio 2.94

Top Fund Holdings for IL30EQY

Filing Date: 02/28/2015
Name Position Value % of Total
Evogene Ltd 59,000 2,387,730 9.564%
Pluristem Therapeutics Inc 184,000 2,222,720 8.903%
Kamada Ltd 120,500 2,146,105 8.596%
Compugen Ltd 62,178 2,143,898 8.587%
OPKO Health Inc 30,000 1,770,300 7.091%
Protalix BioTherapeutics Inc 220,000 1,740,420 6.971%
Mazor Robotics Ltd 72,000 1,700,640 6.812%
Clal Biotechnology Industries 380,001 1,510,502 6.050%
Brainsway Ltd 38,000 1,402,200 5.616%
Elron Electronic Industries Lt 55,000 1,006,500 4.031%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil